Latest News and Press Releases

DOYLESTOWN, Pa., Nov. 24, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. announced today that it has confidentially submitted a draft registration statement to the U.S. Securities and Exchange...

DOYLESTOWN, Pa., Nov. 19, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biopharmaceutical company focused on the research, development and commercialization of oral...

DOYLESTOWN, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral...

OnCore Secures Exclusive Worldwide Rights to NVP018 NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...

Funds to Expand OnCore's Portfolio of Oral Therapeutics for the Treatment of Chronic HBV OnCore to Advance HBV Compounds Into Phase 1 Clinical Development During 2015 Former Pharmasset Team...